These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17311212)

  • 21. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
    Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
    Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaplastic gliomas in adults: an update.
    Izquierdo C; Joubert B; Ducray F
    Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
    Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oligodendrogliomas: their morphological characteristics and molecular alterations].
    Carrato-Monino C; Ariza A
    Rev Neurol; 2007 Mar 16-31; 44(6):353-9. PubMed ID: 17385172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile.
    Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K
    Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
    Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
    J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
    Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.
    Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C
    Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
    Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
    Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
    J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic and predictive factors for gliomas in adults].
    Frenel JS; Botti M; Loussouarn D; Campone M
    Bull Cancer; 2009 Apr; 96(4):357-67. PubMed ID: 19357011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated molecular testing in gliomas: a retrospective study of 53 cases.
    Mahajan D; Prayson RA
    Am J Clin Pathol; 2009 Jul; 132(1):118-24. PubMed ID: 19864242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligodendrogliomas: molecular biology and treatment.
    Bromberg JE; van den Bent MJ
    Oncologist; 2009 Feb; 14(2):155-63. PubMed ID: 19182242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
    Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
    Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant gliomas. Oncogenic considerations].
    Pérez-Ortiz L; Zaldívar-Vaillant T; Tamayo-Suárez JD
    Rev Neurol; 2000 Jul 1-15; 31(1):49-52. PubMed ID: 10948584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.
    Reddy KS
    Cancer Genet Cytogenet; 2008 Jul; 184(2):77-86. PubMed ID: 18617055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
    Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
    Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas.
    Mason WP; Cairncross JG
    Neurology; 2008 Jul; 71(5):365-73. PubMed ID: 18663182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
    Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
    Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.